Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Severe Respiratory Failure in Japan
To evaluate procedures and outcomes of extracorporeal membrane oxygenation (ECMO) therapy applied to 2009 influenza A(H1N1) severe respiratory failure patients in Japan.
Weaning from Venovenous Extracorporeal Membrane Oxygenation without Anticoagulation: Is it Possible?
Based on this single experience, management and weaning without any anticoagulant agent might be possible.
Extracorporeal Membrane Oxygenation in Maternal Arrhythmic Cardiogenic Shock
We report the first case of the use of ECMO for the treatment of cardiac arrhythmia with cardiogenic shock in a pregnant woman.
Outcome of Patients with Profound Cardiogenic Shock after Cardiopulmonary Resuscitation and Prompt Extracorporeal Membrane Oxygenation Support. A Single-Center Observational Study
Profound CS was associated with high mortality. Both successful weaning from ECMO and an APACHE II score might serve as outcome predictors for risk stratification.
20-year Experience of Prolonged Extracorporeal Membrane Oxygenation in Critically Ill Children with Cardiac or Pulmonary Failure
This study aimed to study morbidity and mortality associated with prolonged ECMO therapy (≥28 days) in children with refractory cardiac or pulmonary failure.
Transplantation of Engineered Heart Tissue as a Biological Cardiac Assist Device for Treatment of Dilated Cardiomyopathy
The aim of this study was to characterize an alternative treatment for dilated cardiomyopathy (DCM) using a novel cardiac biological assist device created from engineered heart tissue (EHT).
Bivalirudin Versus Heparin as an Anticoagulant During Extracorporeal Membrane Oxygenation: A Case-Control Study
The aim of this study was to compare bivalirudin-based anticoagulation with heparin-based protocols in a population of patients treated with venovenous or venoarterial extracorporeal membrane oxygenation.
Prolonged Heparin-Free Extracorporeal Membrane Oxygenation in Multiple Injured Acute Respiratory Distress Syndrome Patients with Traumatic Brain Injury
Based on our experience, we recommend the use of heparin-free ECMO in multiple injured patients with pulmonary failure that is not successfully controlled by lung-protective ventilation even if severe TBI is present.
Refusal of Transfusions for Cardiac Surgery Was Not Associated with Shorter Long-Term Survival
In patients having cardiac surgery, prospectively refusing blood transfusions was associated with shorter hospital stays and improved short-term but not long-term survival compared with having transfusions.
Antithrombin Replacement During Extracorporeal Membrane Oxygenation
Our objective is to determine ATIII's effect on anticoagulation and blood loss during ECMO.
Pharmacokinetics and Safety of Fluconazole in Young Infants Supported with Extracorporeal Membrane Oxygenation
This study determined the pharmacokinetics of fluconazole in infants on ECMO.
ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics During Extracorporeal Membrane Oxygenation: A Multi-Centre Study to Optimise Drug Therapy During ECMO
This study was designed to describe the pharmacokinetics of the commonly used antibiotic, analgesic and sedative drugs in adult patients receiving ECMO.